If you’ve gone down the lion’s mane rabbit hole far enough, you’ve probably run into erinacine A. It shows up in clinical trials, gets name-dropped in product descriptions, and occasionally appears on supplement labels. But whether it’s actually in the capsule you’re buying at a dose that does anything is a very different question.
I’ve read the research on erinacine A more carefully than most supplement buyers would want to. What I found is that this is one of the more interesting compounds in the functional mushroom space, backed by real human trial data, and almost completely absent from the vast majority of products that imply it’s there.
Here’s what you actually need to know.
- What erinacine A is
- What the research actually shows
- Why most supplements don’t contain it
- How to tell if a product actually contains it
- The two products that clear the bar
What Erinacine A Is
Erinacine A is a diterpenoid compound produced in the mycelium of Hericium erinaceus. It belongs to a family called erinacines, all of which are produced in the mycelium rather than the fruiting body (the visible mushroom cap most people picture).
Its mechanism: erinacine A stimulates production of nerve growth factor, or NGF, a protein that supports the growth, maintenance, and survival of neurons. This is the same general mechanism that’s attracted researchers to lion’s mane in the first place, and erinacine A is one of the most potent NGF-stimulating compounds identified in the species. Some research suggests it may cross the blood-brain barrier, which is a meaningful distinction from compounds that stimulate NGF in the gut without reaching the brain directly.
It is not the only bioactive in lion’s mane. The fruiting body contains a separate family called hericenones, which also have NGF-stimulating activity. Both matter. But erinacine A specifically is what the most compelling clinical evidence for lion’s mane in humans is built around.
What the Research Actually Shows
The most significant human trial involving erinacine A is the Li 2020 study. It ran for 49 weeks with participants who had mild Alzheimer’s disease, using lion’s mane mycelium capsules standardized to a specific erinacine A content.
The results: daily living scores improved meaningfully compared to placebo. Standard cognitive screening scores didn’t move as much as researchers hoped. So the picture is positive but nuanced. Measurable functional improvement in a population with existing cognitive decline, over nearly a year of consistent use.
A systematic review published in Frontiers in Nutrition (PMC12434001) looked at the broader Hericium erinaceus literature and found consistent positive signals for cognitive outcomes, particularly in older adults and populations with existing cognitive impairment. The evidence base for erinacine A is still building, but the directional signal is clear.
What this research doesn’t show: quick results in healthy younger adults. The conditions that produced positive outcomes were specific populations, meaningful doses of verified material, and long timelines. That context matters if you’re evaluating whether this is worth your money.
For a full breakdown of all the major lion’s mane human trials, including the Mori 2009 and Docherty 2023 studies, the lion’s mane clinical trials article has the complete picture.
Why Most Supplements Don’t Actually Contain It
Erinacine A is produced in mycelium, but not all mycelium produces it in meaningful amounts. It requires specific growing conditions, particularly liquid fermentation (also called submerged fermentation), rather than the solid-state grain cultivation most commercial mycelium supplement manufacturers use.
Growing mycelium on grain is cheaper and more scalable. Liquid fermentation produces higher erinacine A concentrations but requires different equipment and more specialized process control. The commercial incentive points toward grain cultivation. The clinical evidence points toward liquid fermentation.
There’s also a testing problem. Until recently, no commercially available reference standard existed for erinacine A, which is what labs need to accurately quantify it. Without a reference standard, even labs that wanted to test for it couldn’t produce reliable numbers.
The result: independent testing has consistently found that most lion’s mane supplements, including many marketed as mycelium products, contain little to no detectable erinacine A, even products that strongly imply it in their marketing.
How to Tell If a Product Actually Contains It
The only honest answer is a batch-specific Certificate of Analysis from a third-party lab that quantified erinacine A by name, at a specific concentration, using a validated reference standard.
“Erinacines” on a label is not enough. “Mycelium extract” is not enough. “Standardized” without specifying what it’s standardized to is not enough.
What you want to see:
- Erinacine A listed by name, not just “erinacines” or “cyathane diterpenes”
- A milligram amount per serving
- A third-party lab COA, batch-specific, publicly posted or available on request
- Liquid culture or submerged fermentation specified as the production method
If the product doesn’t tell you how much erinacine A is in a serving, it almost certainly doesn’t know. Which usually means there isn’t much.
The Two Products That Actually Clear the Bar
Disclosure: I’m an Amazon affiliate (mycrofarm-20) and earn a commission if you purchase through links here. I only link products that meet the verification criteria above. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Nootropics Depot Erinamax
Erinamax was the first commercially available erinacine A supplement with a verified, specific dose. Each capsule delivers 2.5mg erinacine A, confirmed by batch-specific COAs. Nootropics Depot built their own erinacine A reference standard because no commercial standard existed at the time. Independent testing in 2025 found it delivered over 32 times more erinacine A than competing products, not a claim the company made, but what outside labs found.
The honest note: this is a mycelium-only product. No hericenones from the fruiting body side. If you want to cover both mechanisms, this pairs with a quality fruiting body extract.
Nootropics Depot Erinamax on Amazon
Real Mushrooms Real Mycelium
Real Mushrooms Real Mycelium launched in June 2026 and is the higher-dose option: 5mg erinacine A per two-capsule serving (their ErinaPrime extract), from grain-free, liquid-fermented mycelium, with NSF-audited manufacturing and third-party verification. That’s double the erinacine A per serving compared to Erinamax.
Real Mushrooms Real Mycelium on Amazon
Which One to Choose
If you want a product with a longer track record: Erinamax. If you want the higher erinacine A dose: Real Mycelium. Both are the real thing in a category where most products aren’t.
Neither replaces a quality fruiting body supplement if you want full-spectrum coverage of both hericenones and erinacines. The lion’s mane clinical trials article goes deeper on both mechanisms and what to pair these with.
The Bottom Line
Erinacine A is one of the few lion’s mane compounds with meaningful human clinical trial data behind it. It’s also one of the hardest to find in a supplement at a dose that matches what research has studied. Most products that hint at it don’t actually contain it in any meaningful amount.
If erinacine A is why you’re shopping, the only way to know what you’re getting is a published COA with a specific milligram amount. Right now, two products meet that bar. Everything else is either a fruiting body product (great for hericenones, no erinacine A), grain-cultivated mycelium with ambiguous labeling, or something less honest than it wants to appear.